Rare Subtypes of Gastrointestinal Cancers

Recruiting now

Conditions studied: Cancer of Gastrointestinal Tract

In brief

A single-arm prospective observational translational study of biomarkers in patients receiving targeted treatment for rare subtypes of cancer of the Gastrointestinal Tract.

Key facts

Study ID

NCT04838327

Run by

Aarhus University Hospital

People needed

130

Starts

2021-08-16

Expected to finish

2026-04-01

Last updated by the study team

2024-08-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of a rare subtype of GI cancer including BRAF V600E mutation, MSI-H, HER2 and others
• Diagnosis of cancer of the gastrointestinal tract may be made by histo- or cyto-pathology, or by clinical and imaging criteria
• Planned for targeted treatment
• Age 18 years or older
• Able to understand written information
• Consent to samples for translational research

You may not qualify if…

• Conditions precluding translational blood sampling
• Another concomitant cancer

Where it is running

• Department of Oncology, Aarhus University Hospital — Aarhus N, Denmark (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.